Clinical Trial Update: Combination of Proton Therapy With Immunotherapy in Multiple Metastases Cancer [Phase 1, Phase 2]

View source ↗

Summary

A combined proton therapy and immunotherapy trial in patients with multiple metastases is in Phase 1/2, status not specified.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neoplasm Metastasis

Snippet

Sponsor: Peking University First Hospital | Conditions: Proton Therapy, Immunotherapy | Phase 1, Phase 2 | Status: UNKNOWN